Prothymosin alpha enhances interleukin 2 receptor expression in normal human T-lymphocytes

Area of Science:

• Immunology
• Cell Biology

Background:

• Prothymosin alpha (Pro alpha) is known to modulate immune responses.
• Phytohaemagglutinin (PHA) stimulates human peripheral blood mononuclear cells (PBMC) proliferation.
• Interleukin-2 receptor (IL-2R) is crucial for T-cell activation and proliferation.

Purpose of the Study:

• To investigate if Pro alpha enhances PBMC proliferation by affecting IL-2R expression.
• To determine if Pro alpha influences the number of IL-2R-expressing cells or IL-2R surface density.
• To explore the role of macrophages and IL-2 in Pro alpha's immunomodulatory effects.

Main Methods:

• PBMC from 21 donors were stimulated with PHA at optimal and diluted concentrations.
• Pro alpha's effect on IL-2R expression (cell number and density) and proliferation was assessed.
• Cyclosporin A was used to suppress IL-2 production to evaluate its role.

Main Results:

• Pro alpha significantly increased IL-2R expression in cells with half-maximal responses to PHA (groups Lh and Hl).
• Pro alpha-mediated enhancement of IL-2R expression in group Lh was dose-dependent and correlated with increased proliferation.
• Pro alpha's effect was independent of IL-2 and required macrophages for modulation of PHA-stimulated IL-2R expression.

Conclusions:

• Pro alpha enhances PBMC proliferation by upregulating IL-2R expression, particularly in suboptimal conditions.
• The mechanism appears independent of IL-2 but requires macrophage involvement during lymphocyte activation.
• Pro alpha holds potential for treating T-cell dysfunction in immunodeficiency and aging populations.